195 related articles for article (PubMed ID: 11086270)
1. Implantable cardioverter defibrillators: arrhythmias. A rapid and systematic review.
Parkes J; Bryant J; Milne R
Health Technol Assess; 2000; 4(26):1-69. PubMed ID: 11086270
[TBL] [Abstract][Full Text] [Related]
2. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.
Buxton M; Caine N; Chase D; Connelly D; Grace A; Jackson C; Parkes J; Sharples L
Health Technol Assess; 2006 Aug; 10(27):iii-iv, ix-xi, 1-164. PubMed ID: 16904046
[TBL] [Abstract][Full Text] [Related]
3. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.
Colquitt JL; Mendes D; Clegg AJ; Harris P; Cooper K; Picot J; Bryant J
Health Technol Assess; 2014 Aug; 18(56):1-560. PubMed ID: 25169727
[TBL] [Abstract][Full Text] [Related]
4. The clinical and cost-effectiveness of implantable cardioverter defibrillators: a systematic review.
Bryant J; Brodin H; Loveman E; Payne E; Clegg A
Health Technol Assess; 2005 Sep; 9(36):1-150, iii. PubMed ID: 16153353
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death.
Owens DK; Sanders GD; Harris RA; McDonald KM; Heidenreich PA; Dembitzer AD; Hlatky MA
Ann Intern Med; 1997 Jan; 126(1):1-12. PubMed ID: 8992917
[TBL] [Abstract][Full Text] [Related]
6. Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator.
Owens DK; Sanders GD; Heidenreich PA; McDonald KM; Hlatky MA
Am Heart J; 2002 Sep; 144(3):440-8. PubMed ID: 12228780
[TBL] [Abstract][Full Text] [Related]
7. The cost effectiveness of implantable cardioverter defibrillators: a systematic review of economic evaluations.
Gialama F; Prezerakos P; Maniadakis N
Appl Health Econ Health Policy; 2014 Feb; 12(1):41-9. PubMed ID: 24243517
[TBL] [Abstract][Full Text] [Related]
8. Are implantable cardioverter- defibrillators cost-effective?
Naik AM; Peter CT
Curr Cardiol Rep; 2000 Jul; 2(4):341-5. PubMed ID: 10953269
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of implantable cardioverter defibrillator therapy versus drug therapy for patients at high risk of sudden cardiac death.
Spath MA; O'Brien BJ
Pharmacoeconomics; 2002; 20(11):727-38. PubMed ID: 12201792
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of implantable cardioverter-defibrillators.
Sanders GD; Hlatky MA; Owens DK
N Engl J Med; 2005 Oct; 353(14):1471-80. PubMed ID: 16207849
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of the implantable cardioverter defibrillator: a review of current evidence.
Lynd LD; O'Brien BJ
J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S99-103. PubMed ID: 12950529
[TBL] [Abstract][Full Text] [Related]
12. Cost-benefit analysis of primary prevention of sudden cardiac death with an implantable cardioverter defibrillator versus amiodarone in Canada.
Deniz HB; Ward A; Jaime Caro J; Alvarez P; Sadri H
Curr Med Res Opin; 2009 Mar; 25(3):617-26. PubMed ID: 19232036
[TBL] [Abstract][Full Text] [Related]
13. Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.
Sanders GD; Hlatky MA; Every NR; McDonald KM; Heidenreich PA; Parsons LS; Owens DK
Ann Intern Med; 2001 Nov; 135(10):870-83. PubMed ID: 11712877
[TBL] [Abstract][Full Text] [Related]
14. Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.
Hilleman DE; Bauman AL
Pharmacotherapy; 2001 May; 21(5):556-75. PubMed ID: 11349745
[TBL] [Abstract][Full Text] [Related]
15. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
[TBL] [Abstract][Full Text] [Related]
16. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society.
Silka MJ; Kron J; Dunnigan A; Dick M
Circulation; 1993 Mar; 87(3):800-7. PubMed ID: 8443901
[TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter-defibrillators in arrhythmias: a rapid and systematic review of effectiveness.
Parkes J; Bryant J; Milne R
Heart; 2002 May; 87(5):438-42. PubMed ID: 11997415
[TBL] [Abstract][Full Text] [Related]
18. Cost-benefit analysis of preventing sudden cardiac deaths with an implantable cardioverter defibrillator versus amiodarone.
Caro JJ; Ward A; Deniz HB; O'Brien JA; Ehreth JL
Value Health; 2007; 10(1):13-22. PubMed ID: 17261112
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness of Implantable Cardioverter-Defibrillators in Children with Cardiac Conditions Associated with Risk for Sudden Cardiac Death.
Haag MB; Hersh AR; Toffey DE; Sargent JA; Stecker EC; Heitner SB; Caughey AB; Balaji S
Pediatr Cardiol; 2020 Oct; 41(7):1484-1491. PubMed ID: 32623612
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
